GHC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Graham Holdings Co (GHC) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the technical indicators show a bullish trend, the company's financial performance in the latest quarter indicates significant challenges, including a sharp decline in net income and EPS. Additionally, there are no strong positive catalysts or trading signals to justify immediate action.
The technical indicators show a bullish trend with MACD above 0 and positively contracting, RSI in the neutral zone at 72.684, and bullish moving averages (SMA_5 > SMA_20 > SMA_200). Key resistance levels are at 1136.111 and 1160.262, while support levels are at 1057.927 and 1033.776.
Graham Healthcare Group won the USA TODAY Top Workplaces Award for the third consecutive year, highlighting a strong employee-focused culture.
The company's financial performance in 2025/Q4 showed a significant decline in net income (-80.15% YoY), EPS (-80.29% YoY), and gross margin (-7.52% YoY).
In 2025/Q4, revenue increased slightly by 0.42% YoY to $1.25 billion. However, net income dropped significantly by 80.15% YoY to $108.2 million, EPS fell by 80.29% YoY to 24.7, and gross margin decreased by 7.52% YoY to 27.53%.
No recent analyst rating or price target changes are available for GHC.
